Informed-money record

ELVN · Enliven Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

132

Named actors

Disclosed $ (bull / bear)

$60K / $166.7M

Recent disclosures

25 of 136 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-08-17	CHIEF MEDICAL OFFICER Collins Helen Louise	sold	$228K	SEC ↗
2026-08-17	CHIEF MEDICAL OFFICER Collins Helen Louise	sold	$65K	SEC ↗
2026-08-17	CHIEF FINANCIAL OFFICER Hohl Benjamin	sold	$82K	SEC ↗
2026-08-17	CHIEF FINANCIAL OFFICER Hohl Benjamin	sold	$270K	SEC ↗
2026-08-04	Director Derynck Mika K	sold	$9.6M	SEC ↗

111 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals